| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ARDELYX, INC. | Chief Business Officer | Common Stock | 271K | $1.5M | $5.54 | Nov 21, 2025 | Direct |
| ARDELYX, INC. | Chief Business Officer | Stock Option (Right to Buy) | 205K | $476K | $2.32 | Feb 25, 2025 | Direct |
| CAPRICOR THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 5.75K | Jan 2, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ARDX | ARDELYX, INC. | Nov 21, 2025 | 1 | -$30.8K | 4 | Nov 25, 2025 | Chief Business Officer |
| ARDX | ARDELYX, INC. | Aug 21, 2025 | 1 | -$32.1K | 4 | Aug 28, 2025 | Chief Business Officer |
| ARDX | ARDELYX, INC. | May 20, 2025 | 1 | -$59.3K | 4 | May 22, 2025 | Officer |
| ARDX | ARDELYX, INC. | Feb 25, 2025 | 2 | $0 | 4 | Feb 27, 2025 | Executive Vice President, Corporate Development and Strategy |
| CAPR | CAPRICOR THERAPEUTICS, INC. | Jan 2, 2025 | 3 | $0 | 4 | Jan 6, 2025 | Director |
| ARDX | ARDELYX, INC. | Mar 25, 2024 | 2 | $0 | 4 | Mar 27, 2024 | Executive Vice President, Corporate Development and Strategy |
| ARDX | ARDELYX, INC. | Mar 25, 2024 | 0 | $0 | 3 | Mar 27, 2024 | Executive Vice President, Corporate Development and Strategy |
| CAPR | CAPRICOR THERAPEUTICS, INC. | Jan 2, 2024 | 4 | $0 | 4 | Jan 4, 2024 | Director |
| CAPR | CAPRICOR THERAPEUTICS, INC. | Sep 1, 2023 | 1 | $0 | 4 | Sep 6, 2023 | Director |
| CAPR | CAPRICOR THERAPEUTICS, INC. | Sep 1, 2023 | 0 | $0 | 3 | Sep 6, 2023 | Director |